1. A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertension. Issue 4 (April 2018) Authors: Cushman, William C.; Bakris, George L.; White, William B.; Weber, Michael A.; Sica, Domenic; Roberts, Andrew; Lloyd, Eric; Kupfer, Stuart Journal: Journal of hypertension Issue: Volume 36:Issue 4(2018:Apr.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin. Issue 3 (September 2016) Authors: White, William B.; Wilson, Craig A.; Bakris, George L.; Bergenstal, Richard M.; Cannon, Christopher P.; Cushman, William C.; Heller, Simon K.; Mehta, Cyrus R.; Nissen, Steven E.; Zannad, Faiez; Kupfer, Stuart Journal: Hypertension Issue: Volume 68:Issue 3(2016:Sep.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document. (October 2013) Authors: Zannad, Faiez; Garcia, Angeles Alonso; Anker, Stefan D.; Armstrong, Paul W.; Calvo, Gonzalo; Cleland, John G.F.; Cohn, Jay N.; Dickstein, Kenneth; Domanski, Michael J.; Ekman, Inger; Filippatos, Gerasimos S.; Gheorghiade, Mihai; Hernandez, Adrian F.; Jaarsma, Tiny; Koglin, Joerg; Konstam, Marvin;... Journal: European journal of heart failure Issue: Volume 15:Number 10(2013) Page Start: 1082 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Developments in Exercise Capacity Assessment in Heart Failure Clinical Trials and the Rationale for the Design of METEORIC-HF. (3rd March 2022) Authors: Lewis, Gregory D.; Docherty, Kieran F.; Voors, Adriaan A.; Cohen-Solal, Alain; Metra, Marco; Whellan, David J.; Ezekowitz, Justin A.; Ponikowski, Piotr; Böhm, Michael; Teerlink, John R.; Heitner, Stephen B.; Kupfer, Stuart; Malik, Fady I.; Meng, Lisa; Felker, G. Michael Journal: Circulation Issue: Volume 15:Number 5(2022) Page Start: e008970 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effects of azilsartan medoxomil compared with olmesartan and valsartan on ambulatory and clinic blood pressure in patients with type 2 diabetes and prediabetes. Issue 4 (April 2016) Authors: White, William B.; Cuadra, René H.; Lloyd, Eric; Bakris, George L.; Kupfer, Stuart Journal: Journal of hypertension Issue: Volume 34:Issue 4(2016:Apr.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effects of azilsartan medoxomil compared with olmesartan and valsartan on ambulatory and clinic blood pressure in patients with type 2 diabetes and prediabetes. Issue 4 (April 2016) Authors: White, William B.; Cuadra, René H.; Lloyd, Eric; Bakris, George L.; Kupfer, Stuart Journal: Journal of hypertension Issue: Volume 34:Issue 4(2016:Apr.) Page Start: 788 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial. (22nd May 2022) Authors: Metra, Marco; Pagnesi, Matteo; Claggett, Brian L; Díaz, Rafael; Felker, G Michael; McMurray, John J V; Solomon, Scott D; Bonderman, Diana; Fang, James C; Fonseca, Cândida; Goncalvesova, Eva; Howlett, Jonathan G; Li, Jing; O'Meara, Eileen; Miao, Zi Michael; Abbasi, Siddique A; Heitner, Stephen B; ... Journal: European heart journal Issue: Volume 43:Number 48(2022) Page Start: 5006 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N‐terminal pro‐B‐type natriuretic peptide level: insights from the GALACTIC‐HF trial. (16th January 2023) Authors: Docherty, Kieran F.; McMurray, John J.V.; Claggett, Brian L.; Miao, Zi Michael; Adams, Kirkwood F.; Arias‐Mendoza, Alexandra; Cleland, John G.F.; Diaz, Rafael; Echeverria Correa, Luis E; Felker, G. Michael; Fonseca, Candida; Li, Jing; Metra, Marco; Sliwa‐Hahnle, Karen; Solomon, Scott D.; Vandeker... Journal: European journal of heart failure Issue: Volume 25:Number 2(2023) Page Start: 248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Evaluation of the angiotensin II receptor blocker azilsartan medoxomil in African‐American patients with hypertension. Issue 7 (11th May 2017) Authors: Johnson, Wallace; White, William B.; Sica, Domenic; Bakris, George L.; Weber, Michael A.; Handley, Alison; Perez, Alfonso; Cao, Charlie; Kupfer, Stuart; Saunders, Elijah B. Journal: Journal of clinical hypertension Issue: Volume 19:Issue 7(2017) Page Start: 695 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. EXAMINE: targeting risk and treatment in diabetes – Authors' reply. Issue 10002 (10th October 2015) Authors: White, William B; Kupfer, Stuart; Zannad, Faiez Journal: Lancet Issue: Volume 386:Issue 10002(2015) Page Start: 1445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗